Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
Regeneron Announces Prelim. Data In An ASGCT Presentation Showing DB-OTO Improved Hearing To Normal Levels In One Child Within 24 Weeks, Initial Hearing Improvements Observed In A Second Child At 6-Week Assessment
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.